PATRICIA LEWIS: Open Payments
NPI 1457307662 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 72 payments from 15 companies in 2025. Trend: 2023 $390 · 2024 $1,271 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $448 |
| Aimmune Therapeutics, Inc. | 13 | $226 |
| PFIZER INC. | 11 | $140 |
| Enterra Medical, Inc. | 1 | $136 |
| Janssen Biotech, Inc. | 5 | $118 |
| Novo Nordisk Inc | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Madrigal Pharmaceuticals | 2 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: ZENPEP, RINVOQ, SKYRIZI, TREMFYA, XELJANZ, ENTYVIO, REZDIFFRA, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
